Phase IIa study of vamifeport in patients with non-transfusion-dependent beta-thalassemia
1 year ago
[{"url":"https://i.ytimg.com/vi/YbFdb4bi9SA/hq720.jpg?sqp=-oaymwEcCOgCEMoBSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLD3i7Gv6kso1fipX0Ax1xW5RBCBXw","width":360,"height":202},{"url":"https://i.ytimg.com/vi/YbFdb4bi9SA/hq720.jpg?sqp=-oaymwEcCNAFEJQDSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLCbP3AHfJF6qZvbQKoqNPvY14PU6w","width":720,"height":404}]
{"url":"https://i.ytimg.com/an_webp/YbFdb4bi9SA/mqdefault_6s.webp?du=3000&sqp=CKDvsKkG&rs=AOn4CLB3p2seK-tPmEV2kid3o1QcmfF-5A","width":320,"height":180}
[{"text":"Ali Taher, MD, PhD, American University of Beirut Medical Center, Beirut, Lebanon, outlines the mechanism of action of vamifeport\u00a0..."}]
{"name":"VJHemOnc \u2013 Video Journal of Hematological Oncology","id":"UCsQXL4_zTA-FoG9RA1tEGiw","thumbnails":[{"url":"https://yt3.ggpht.com/tLfkaYbACnFuAto-jU_XMyorvysy280aW3Kj1oDAKOH7nd58XYlz5rEL24x9ScNjruMr2YYw9w=s68-c-k-c0x00ffffff-no-rj","width":68,"height":68}],"link":"https://www.youtube.com/channel/UCsQXL4_zTA-FoG9RA1tEGiw"}
{"title":"Phase IIa study of vamifeport in patients with non-transfusion-dependent beta-thalassemia by VJHemOnc \u2013 Video Journal of Hematological Oncology 60 views 1 year ago 3 minutes, 26 seconds","duration":"3 minutes, 26 seconds"}